NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $67.52 +1.62 (+2.46%) As of 04/24/2025 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Solventum alerts:Sign Up Key Stats Today's Range$65.84▼$67.6750-Day Range$63.04▼$83.8352-Week Range$47.16▼$85.92Volume750,907 shsAverage Volume1.31 million shsMarket Capitalization$11.68 billionP/E Ratio24.55Dividend YieldN/APrice Target$79.86Consensus RatingHold Company OverviewSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More… Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks32nd Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 32% of companies evaluated by MarketBeat, and ranked 836th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingSolventum has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 8 hold ratings, and 1 sell rating.Amount of Analyst CoverageSolventum has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-16.57% Earnings GrowthEarnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 24.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 24.55, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.18.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.94. PEG Ratios above 1 indicate that a company could be overvalued.Read more about Solventum's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.05% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently decreased by 2.76%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.05% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently decreased by 2.76%, indicating that investor sentiment is improving. News and Social Media2.7 / 5News Sentiment0.85 News SentimentSolventum has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Solventum this week, compared to 10 articles on an average week.Search InterestOnly 5 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.05% of the stock of Solventum is held by insiders.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Email Address SOLV Stock News Headlines3M Co: A company with a sound balance sheet, and mixed shareholder distributions.April 23 at 11:21 AM | uk.finance.yahoo.comGrin Unveils New AI-Enabled Management Tools and Seamless Practice Integration at AAO 2025April 23 at 11:21 AM | finance.yahoo.comTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…April 25, 2025 | Paradigm Press (Ad)Analysts Set Solventum Co. (NYSE:SOLV) PT at $79.86April 23 at 1:31 AM | americanbankingnews.com3M Earnings Will Be Scoured for Tariff ImpactsApril 21, 2025 | msn.comSolventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025April 17, 2025 | gurufocus.comSolventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025April 17, 2025 | prnewswire.comSolventum Corporation (NYSE:SOLV): Is the Spin-Off a Blessing in Disguise?April 14, 2025 | msn.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.06 at the start of the year. Since then, SOLV shares have increased by 2.2% and is now trading at $67.52. View the best growth stocks for 2025 here. How were Solventum's earnings last quarter? Solventum Co. (NYSE:SOLV) issued its quarterly earnings data on Thursday, November, 7th. The company reported $1.15 EPS for the quarter, missing analysts' consensus estimates of $1.38 by $0.23. The company earned $2.08 billion during the quarter, compared to the consensus estimate of $2.05 billion. Read the conference call transcript. Who are Solventum's major shareholders? Top institutional shareholders of Solventum include Assenagon Asset Management S.A. (0.33%), Wedge Capital Management L L P NC (0.29%), GAMMA Investing LLC (0.20%) and Rhumbline Advisers (0.17%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol-Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings11/07/2024Today4/24/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees22,000Year FoundedN/APrice Target and Rating Average Stock Price Target$79.86 High Stock Price Target$85.00 Low Stock Price Target$71.00 Potential Upside/Downside+18.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio24.43 Forward P/E Ratio10.23 P/E Growth1.94Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.45 Current Ratio1.15 Quick Ratio0.83 Sales & Book Value Annual Sales$8.25 billion Price / Sales1.41 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares173,003,000Free FloatN/AMarket Cap$11.64 billion OptionableOptionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NYSE:SOLV) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.